Yesterday was international food day the @LinardicLabDuke, Deel lab, Blobe lab, and Watts lab!!!
We love celebrating and learning about each other ♥️
Representation from 🇱🇧 to 🇮🇳 to 🇺🇸 to 🇨🇳 and more!
Join us on Apr 9 for Day 1 of the Samuel L. Katz 2024 Research Retreat! Dive into a Special Grand Rounds with Dr. Bruce Gelb’s keynote on Noonan Syndrome & related disorders. The session wraps up with a Fireside Chat with Dr. Gelb. Don’t miss out! #ResearchRetreat@Duke_Childrens
Please join us in congratulating a past Linardic Lab summer student, Audrey Chambers, in accepting an offer to @UWMadison where she will be completing her PhD in Molecular and Cellular Pharmacology!!!
We are so proud of you! 🎉
It's the end of August! This means it's time for a #MilestoneMoment! Our first milestone for the month was shared with us by @ElizabethM_MS of the @LinardicLabDuke. Congratulations on your acceptance!
Our lab participated in the Connective Tissue Oncology Society Conference in Vancouver. We had an oral presentation and a poster to share our work in pediatric oncology research.
🎗🎗🎗🎗
Postdoctoral Associate position @LinardicLabDuke !
We are looking for a motivated team member to join our childhood cancer translational research team at Duke.
If you are interested check this link to apply: https://t.co/sHjzmAjGXe
@PostdocPal@MinionPostDoc@PostdocO
🔖Something for your weekend reading list!
Identification and targeting of a HES1-YAP1-CDKN1C functional interaction in fusion-negative rhabdomyosarcoma
🔗https://t.co/fhR97DUGMx
#Rhabdomyosarcoma#YAP1#SRCST
Yesterday was international food day the @LinardicLabDuke, Deel lab, Blobe lab, and Watts lab!!!
We love celebrating and learning about each other ♥️
Representation from 🇱🇧 to 🇮🇳 to 🇺🇸 to 🇨🇳 and more!
Dr. Ozgun Le Roux and colleagues in the Counter lab discover that different KRAS mutations impart unique quantitative and qualitative signaling outputs, which in turn are preferentially capable of inducing tumor initiation in cell-specific manner. @DukeCancer
���🚨 NEW PAPER ALERT 🚨 🚨
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome..
#RhandomyosarcomaResearch